Karen S. Lynch - 12 Feb 2024 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Footnote F1

Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's 2017 Incentive Compensation Plan on April 1, 2021. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 12, 2024.

Footnote F2

Represents Aetna Inc. Stock Appreciation Rights ("SARs") granted under the Aetna Inc. 2010 Incentive Plan (the "Aetna Plan") on February 17, 2017 that were converted into CVS Health SARs in November 2018 pursuant to the terms of the CVS/Aetna Merger Agreement. These SARs vested in two substantially equal annual installments beginning on February 17, 2019.

Footnote F3

Represents SARs granted under the Aetna Plan on February 19, 2016 that were converted into CVS Health SARs in November 2018 pursuant to the terms of the CVS/Aetna Merger Agreement. These SARs vested on February 19, 2019.

Footnote F4

Represents unvested SARs granted under the Aetna Plan on February 19, 2016 that were converted into CVS Health SARs pursuant to the terms of the CVS/Aetna Merger Agreement. These SARs vested on February 19, 2019.

Footnote F5

Option became exercisable in four equal annual installments, commencing 4/1/2020.

Footnote F6

The number of shares subject to the option were calculated using a 30-day average price.

Footnote F7

Option became exercisable in four equal installments, commencing 4/1/2021.

Footnote F8

Option became exercisable in four equal installments, commencing 4/1/2022.

Footnote F9

Option became exercisable in four equal installments, commencing 4/1/2023.

Footnote F10

Option becomes exercisable in four equal annual installments, commencing 4/1/2024.